Roland Kozlowski, PhD

Roland Kozlowski received a first class honours degree from the University of Bath and a PhD from the University of Cambridge. He is a bioentrepreneur who has worked in the industry since the mid 1990s. Roland is presently Chief Executive Officer and a founder of Lectus Therapeutics Limited. Previously he was Chief Executive Officer and co-founder of Sense Proteomic Limited, which he sold to Procognia Limited in 2002. In the mid 1990s Roland worked with Oxford Molecular PLC on a deal negotiated with Yamanouchi Pharmaceutical Co., Ltd. (now Astellas Pharma Inc). During his career Roland has gained transactional experience ranging from company sale, purchase, financing and in- and out-licensing. Earlier his career Roland ran a Research Group at the University of Oxford and published in the field of ion channel physiology and pharmacology. He now maintains an academic link through a Visiting Industrial Professorship at Bristol University. Roland is a non-executive director of London Genetics which operates in the personalised medicine space and has served on the main board of the Bio Industry Association.